DC-SCRIPT regulates glucocorticoid receptor function and expression of its target GILZ in dendritic cells

Journal of Immunology

Volumn 190, Issue 7, 2013, Pages 3172-3179

  Hontelez, Saartje ^a   Karthaus, Nina ^a   Looman, Maaike W ^a   Ansems, Marleen ^a   Adema, Gosse J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DC SCRIPT PROTEIN; GLUCOCORTICOID INDUCIBLE LEUCINE ZIPPER PROTEIN; GLUCOCORTICOID RECEPTOR; HYBRID PROTEIN; LEUCINE ZIPPER PROTEIN; MESSENGER RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; EMBRYO; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION; UPREGULATION;

CARRIER PROTEINS; CELL LINE; CELLS, CULTURED; DENDRITIC CELLS; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNE TOLERANCE; IMMUNOPRECIPITATION; LEUCINE ZIPPERS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RECEPTORS, GLUCOCORTICOID; RNA ISOFORMS; TRANSCRIPTION, GENETIC;

EID: 84875446316     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201776     Document Type: Article

References (44)

1. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
2. Baschant, U., and J. Tuckermann. 2010. The role of the glucocorticoid receptor in inflammation and immunity. J. Steroid Biochem. Mol. Biol. 120: 69-75.
3. Cohen, N., E. Mouly, H. Hamdi, M. C. Maillot, M. Pallardy, V. Godot, F. Capel, A. Balian, S. Naveau, P. Galanaud, et al. 2006. GILZ expression in human dendritic cells redirects their maturation and prevents antigen-specific T lymphocyte response. Blood 107: 2037-2044.
4. Truckenmiller, M. E., R. H. Bonneau, and C. C. Norbury. 2006. Stress presents a problem for dendritic cells: corticosterone and the fate of MHC class I antigen processing and presentation. Brain Behav. Immun. 20: 210-218.
5. Truckenmiller, M. E., M. F. Princiotta, C. C. Norbury, and R. H. Bonneau. 2005. Corticosterone impairs MHC class I antigen presentation by dendritic cells via reduction of peptide generation. J. Neuroimmunol. 160: 48-60.
6. Elftman, M. D., C. C. Norbury, R. H. Bonneau, and M. E. Truckenmiller. 2007. Corticosterone impairs dendritic cell maturation and function. Immunology 122: 279-290.
7. Rea, D., C. van Kooten, K. E. van Meijgaarden, T. H. Ottenhoff, C. J. Melief, and R. Offringa. 2000. Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10. Blood 95: 3162-3167.
8. Vieira, P. L., P. Kalinski, E. A. Wierenga, M. L. Kapsenberg, and E. C. de Jong. 1998. Glucocorticoids inhibit bioactive IL-12p70 production by in vitro-generated human dendritic cells without affecting their T cell stimulatory potential. J. Immunol. 161: 5245-5251.
9. Roca, L., S. Di Paolo, V. Petruzzelli, G. Grandaliano, E. Ranieri, F. P. Schena, and L. Gesualdo. 2007. Dexamethasone modulates interleukin-12 production by inducing monocyte chemoattractant protein-1 in human dendritic cells. Immunol. Cell Biol. 85: 610-616.
10. Matyszak, M. K., S. Citterio, M. Rescigno, and P. Ricciardi-Castagnoli. 2000. Differential effects of corticosteroids during different stages of dendritic cell maturation. Eur. J. Immunol. 30: 1233-1242.
11. Moser, M., T. De Smedt, T. Sornasse, F. Tielemans, A. A. Chentoufi, E. Muraille, M. Van Mechelen, J. Urbain, and O. Leo. 1995. Glucocorticoids down-regulate dendritic cell function in vitro and in vivo. Eur. J. Immunol. 25: 2818-2824.
12. Bosma, B. M., H. J. Metselaar, N. M. Nagtzaam, R. de Haan, S. Mancham, L. J. van der Laan, E. J. Kuipers, and J. Kwekkeboom. 2008. Dexamethasone transforms lipopolysaccharide-stimulated human blood myeloid dendritic cells into myeloid dendritic cells that prime interleukin-10 production in T cells. Immunology 125: 91-100.
13. Matta, B. M., A. Castellaneta, and A. W. Thomson. 2010. Tolerogenic plasmacytoid DC. Eur. J. Immunol. 40: 2667-2676.
14. Necela, B. M., and J. A. Cidlowski. 2004. Mechanisms of glucocorticoid receptor action in noninflammatory and inflammatory cells. Proc. Am. Thorac. Soc. 1: 239-246.
15. Lu, N. Z., and J. A. Cidlowski. 2004. The origin and functions of multiple human glucocorticoid receptor isoforms. Ann. N. Y. Acad. Sci. 1024: 102-123.
16. Lu, N. Z., and J. A. Cidlowski. 2005. Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. Mol. Cell 18: 331-342.
17. Lu, N. Z., and J. A. Cidlowski. 2006. Glucocorticoid receptor isoforms generate transcription specificity. Trends Cell Biol. 16: 301-307.
18. Oakley, R. H., M. Sar, and J. A. Cidlowski. 1996. The human glucocorticoid receptor beta isoform: expression, biochemical properties, and putative function. J. Biol. Chem. 271: 9550-9559.
19. Ansems, M., S. Hontelez, N. Karthaus, P. N. Span, and G. J. Adema. 2010. Crosstalk and DC-SCRIPT: expanding nuclear receptor modulation. Biochim. Biophys. Acta 1806: 193-199.
20. Ansems, M., S. Hontelez, M. W. Looman, N. Karthaus, P. Bult, J. J. Bonenkamp, J. H. Jansen, F. C. Sweep, P. N. Span, and G. J. Adema. 2010. DC-SCRIPT: nuclear receptor modulation and prognostic significance in primary breast cancer. J. Natl. Cancer Inst. 102: 54-68.
21. Sieuwerts, A. M., M. Ansems, M. P. Look, P. N. Span, V. de Weerd, A. van Galen, J. A. Foekens, G. J. Adema, and J. W. Martens. 2010. Clinical significance of the nuclear receptor co-regulator DC-SCRIPT in breast cancer: an independent retrospective validation study. Breast Cancer Res. 12: R103.
22. Ansems, M., N. Karthaus, S. Hontelez, T. Aalders, M. W. Looman, G. W. Verhaegh, J. A. Schalken, and G. J. Adema. 2012. DC-SCRIPT: AR and VDR regulator lost upon transformation of prostate epithelial cells. Prostate 72: 1708-1717.
23. Triantis, V., V. Moulin, M. W. Looman, F. C. Hartgers, R. A. Janssen, and G. J. Adema. 2006. Molecular characterization of the murine homologue of the DC-derived protein DC-SCRIPT. J. Leukoc. Biol. 79: 1083-1091
24. Triantis, V., D. E. Trancikova, M. W. Looman, F. C. Hartgers, R. A. Janssen, and G. J. Adema. 2006. Identification and characterization of DC-SCRIPT, a novel dendritic cell-expressed member of the zinc finger family of transcriptional regulators. J. Immunol. 176: 1081-1089.
25. Hontelez, S., M. Ansems, N. Karthaus, M. Zuidscherwoude, M. W. Looman, V. Triantis, and G. J. Adema. 2012. Dendritic cell-specific transcript: dendritic cell marker and regulator of TLR-induced cytokine production. J. Immunol. 189: 138-145.
26. de Vries, I. J., A. A. Eggert, N. M. Scharenborg, J. L. Vissers, W. J. Lesterhuis, O. C. Boerman, C. J. Punt, G. J. Adema, and C. G. Figdor. 2002. Phenotypical and functional characterization of clinical grade dendritic cells. J. Immunother. 25: 429-438.
27. Schuurhuis, D. H., W. J. Lesterhuis, M. Kramer, M. G. Looman, M. van Hout-Kuijer, G. Schreibelt, A. C. Boullart, E. H. Aarntzen, D. Benitez-Ribas, C. G. Figdor, et al. 2009. Polyinosinic polycytidylic acid prevents efficient antigen expression after mRNA electroporation of clinical grade dendritic cells. Cancer Immunol. Immunother. 58: 1109-1115.
28. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC(T)) Method. Methods 25: 402-408.
29. Cato, A. C., P. Skroch, J. Weinmann, P. Butkeraitis, and H. Ponta. 1988. DNA sequences outside the receptor-binding sites differently modulate the responsiveness of the mouse mammary tumour virus promoter to various steroid hormones. EMBO J. 7: 1403-1410.
30. Le Ricousse, S., F. Gouilleux, D. Fortin, V. Joulin, and H. Richard-Foy. 1996. Glucocorticoid and progestin receptors are differently involved in the cooperation with a structural element of the mouse mammary tumor virus promoter. Proc. Natl. Acad. Sci. USA 93: 5072-5077.
31. Brüggemeier, U., M. Kalff, S. Franke, C. Scheidereit, and M. Beato. 1991. Ubiquitous transcription factor OTF-1 mediates induction of the MMTV promoter through synergistic interaction with hormone receptors. Cell 64: 565-572.
32. Gowland, P. L., and E. Buetti. 1989. Mutations in the hormone regulatory element of mouse mammary tumor virus differentially affect the response to progestins, androgens, and glucocorticoids. Mol. Cell. Biol. 9: 3999-4008.
33. Toohey, M. G., J. W. Lee, M. Huang, and D. O. Peterson. 1990. Functional elements of the steroid hormone-responsive promoter of mouse mammary tumor virus. J. Virol. 64: 4477-4488.
34. Lopez-Garcia, J., M. Periyasamy, R. S. Thomas, M. Christian, M. Leao, P. Jat, K. B. Kindle, D. M. Heery, M. G. Parker, L. Buluwela, et al. 2006. ZNF366 is an estrogen receptor corepressor that acts through CtBP and histone deacetylases. Nucleic Acids Res. 34: 6126-6136.
35. Plevin, M. J., M. M. Mills, and M. Ikura. 2005. The LxxLL motif: a multifunctional binding sequence in transcriptional regulation. Trends Biochem. Sci. 30: 66-69.
36. Perissi, V., and M. G. Rosenfeld. 2005. Controlling nuclear receptors: the circular logic of cofactor cycles. Nat. Rev. Mol. Cell Biol. 6: 542-554.
37. Chen, Y., A. Kerimo, S. Khan, and L. N. Wei. 2002. Real-time analysis of molecular interaction of retinoid receptors and receptor-interacting protein 140 (RIP140). Mol. Endocrinol. 16: 2528-2537.
38. Li, D., V. Desai-Yajnik, E. Lo, M. Schapira, R. Abagyan, and H. H. Samuels. 1999. NRIF3 is a novel coactivator mediating functional specificity of nuclear hormone receptors. Mol. Cell. Biol. 19: 7191-7202.
39. Zhou, Z. X., B. He, S. H. Hall, E. M. Wilson, and F. S. French. 2002. Domain interactions between coregulator ARA(70) and the androgen receptor (AR). Mol. Endocrinol. 16: 287-300.
40. Hontelez, S., M. Ansems, N. Karthaus, M. Zuidscherwoude, M. W. Looman, V. Triantis, and G. J. Adema. 2012. Dendritic cell-specific transcript: dendritic cell marker and regulator of TLR-induced cytokine production. J. Immunol. 189: 138-145.
41. Ayroldi, E., and C. Riccardi. 2009. Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action. FASEB J. 23: 3649-3658.
42. Steinman, R. M., D. Hawiger, and M. C. Nussenzweig. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21: 685-711.
43. Meijsing, S. H., M. A. Pufall, A. Y. So, D. L. Bates, L. Chen, and K. R. Yamamoto. 2009. DNA binding site sequence directs glucocorticoid receptor structure and activity. Science 324: 407-410.
44. Szatmari, I., and L. Nagy. 2008. Nuclear receptor signalling in dendritic cells connects lipids, the genome and immune function. EMBO J. 27: 2353-2362.